Entrada Therapeutics
TRDA
TRDA
52 hedge funds and large institutions have $361M invested in Entrada Therapeutics in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 4 closing their positions.
Holders
52
Holders Change
+5
Holders Change %
+10.64%
% of All Funds
0.83%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
9
Increased
24
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Millennium Management
New York
|
$2.86M |
| 2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$2.85M |
| 3 |
3
Jane Street
New York
|
$1.07M |
| 4 |
CA
4
CHI Advisors
New York
|
$817K |
| 5 |
HF
5
HRT Financial
New York
|
$556K |
